{"id":3747,"date":"2020-06-10T09:22:15","date_gmt":"2020-06-10T08:22:15","guid":{"rendered":"https:\/\/ppra.inserm.dev-mlcom.net\/?p=3747"},"modified":"2023-07-24T10:39:47","modified_gmt":"2023-07-24T09:39:47","slug":"linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/","title":{"rendered":"L\u2019Inserm porte sept projets europ\u00e9ens d\u2019excellence, inclus le projet sur l\u2019antibior\u00e9sistance de Jean-Claude Sirard, Directeur de recherche de l\u2019\u00e9quipe \u00ab Bact\u00e9ries, antibiotiques et immunit\u00e9 (Inserm U1019, Lille)."},"content":{"rendered":"\n<p>Gr\u00e2ce \u00e0 l&#8217;aide d&#8217;Inserm Transfert, sept nouveaux projets europ\u00e9ens lanc\u00e9s en 2020 sont port\u00e9s et coordonn\u00e9s par des chercheurs Inserm, inclus le projet \u00ab<em> Fair* : Combattre les pneumonies bact\u00e9riennes r\u00e9sistantes \u00e0 l&#8217;antibioth\u00e9rapie <\/em>\u00bb, cordonn\u00e9e par Jean-Claude Sirard.<\/p>\n\n\n\n<p><br>Le but du projet Fair est de tester chez l\u2019humain une nouvelle strat\u00e9gie th\u00e9rapeutique pour les pneumonies bact\u00e9riennes r\u00e9sistantes \u00e0 l\u2019antibioth\u00e9rapie, en exploitant une prot\u00e9ine bact\u00e9rienne capable de stimuler les d\u00e9fenses immunitaires anti-infectieuses. Innovante est aussi la voie orale d\u2019administration, qui permettra de d\u00e9livrer le principe actif dans le tissu infect\u00e9 et r\u00e9duira les effets ind\u00e9sirables dans les autres tissues.<\/p>\n\n\n\n<p><br>L&#8217;Inserm apporte son expertise en recherche fondamentale et clinique \u00e0 travers six unit\u00e9s de recherche, le p\u00f4le de recherche clinique et un centre d&#8217;investigation clinique pour l&#8217;\u00e9tude de phase I. Inserm Transfert soutient le volet administratif et la valorisation.<\/p>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>Lien de la publication : <a href=\"https:\/\/intranet.inserm.fr\/actualites\/Pages\/detail.aspx?news_id=319\" target=\"_blank\" aria-label=\"undefined (s\u2019ouvre dans un nouvel onglet)\" rel=\"noreferrer noopener\">https:\/\/intranet.inserm.fr\/actualites\/Pages\/detail.aspx?news_id=319<\/a><\/p>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><em>* Flagellin Aerosol therapy as an Immunomodulatory adjunct to the antibiotic treatment of drug-Resistant bacterial pneumonia &#8211; Immunoth\u00e9rapie par n\u00e9bulisation de flagelline dans les pneumonies r\u00e9sistantes aux antibiotiques<\/em><\/p><cite><em>En savoir plus sur <\/em><a href=\"http:\/\/fair-flagellin.eu\/\" target=\"_blank\" rel=\"noreferrer noopener\"><em>fair-flagellin.eu<\/em><\/a><\/cite><\/blockquote>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gr\u00e2ce \u00e0 l&#8217;aide d&#8217;Inserm Transfert, sept nouveaux projets europ\u00e9ens lanc\u00e9s en 2020 sont port\u00e9s et coordonn\u00e9s par des chercheurs Inserm, inclus le projet \u00ab Fair* : Combattre les pneumonies bact\u00e9riennes r\u00e9sistantes \u00e0 l&#8217;antibioth\u00e9rapie \u00bb, cordonn\u00e9e par Jean-Claude Sirard. Le but du projet Fair est de tester chez l\u2019humain une nouvelle strat\u00e9gie th\u00e9rapeutique pour les pneumonies [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":189,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L\u2019Inserm porte sept projets europ\u00e9ens d\u2019excellence, inclus le projet sur l\u2019antibior\u00e9sistance de Jean-Claude Sirard, Directeur de recherche de l\u2019\u00e9quipe \u00ab Bact\u00e9ries, antibiotiques et immunit\u00e9 (Inserm U1019, Lille). - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019Inserm porte sept projets europ\u00e9ens d\u2019excellence, inclus le projet sur l\u2019antibior\u00e9sistance de Jean-Claude Sirard, Directeur de recherche de l\u2019\u00e9quipe \u00ab Bact\u00e9ries, antibiotiques et immunit\u00e9 (Inserm U1019, Lille). - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-10T08:22:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-24T09:39:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.png\" \/>\n\t<meta property=\"og:image:width\" content=\"240\" \/>\n\t<meta property=\"og:image:height\" content=\"97\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"L\u2019Inserm porte sept projets europ\u00e9ens d\u2019excellence, inclus le projet sur l\u2019antibior\u00e9sistance de Jean-Claude Sirard, Directeur de recherche de l\u2019\u00e9quipe \u00ab Bact\u00e9ries, antibiotiques et immunit\u00e9 (Inserm U1019, Lille).\",\"datePublished\":\"2020-06-10T08:22:15+00:00\",\"dateModified\":\"2023-07-24T09:39:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/\"},\"wordCount\":238,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.png\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#respond\"]}]},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/\",\"name\":\"L\u2019Inserm porte sept projets europ\u00e9ens d\u2019excellence, inclus le projet sur l\u2019antibior\u00e9sistance de Jean-Claude Sirard, Directeur de recherche de l\u2019\u00e9quipe \u00ab Bact\u00e9ries, antibiotiques et immunit\u00e9 (Inserm U1019, Lille). - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.png\",\"datePublished\":\"2020-06-10T08:22:15+00:00\",\"dateModified\":\"2023-07-24T09:39:47+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.png\",\"width\":240,\"height\":97,\"caption\":\"Cr\u00e9dit : Inserm\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"L\u2019Inserm porte sept projets europ\u00e9ens d\u2019excellence, inclus le projet sur l\u2019antibior\u00e9sistance de Jean-Claude Sirard, Directeur de recherche de l\u2019\u00e9quipe \u00ab Bact\u00e9ries, antibiotiques et immunit\u00e9 (Inserm U1019, Lille).\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u2019Inserm porte sept projets europ\u00e9ens d\u2019excellence, inclus le projet sur l\u2019antibior\u00e9sistance de Jean-Claude Sirard, Directeur de recherche de l\u2019\u00e9quipe \u00ab Bact\u00e9ries, antibiotiques et immunit\u00e9 (Inserm U1019, Lille). - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/","og_locale":"en_GB","og_type":"article","og_title":"L\u2019Inserm porte sept projets europ\u00e9ens d\u2019excellence, inclus le projet sur l\u2019antibior\u00e9sistance de Jean-Claude Sirard, Directeur de recherche de l\u2019\u00e9quipe \u00ab Bact\u00e9ries, antibiotiques et immunit\u00e9 (Inserm U1019, Lille). - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2020-06-10T08:22:15+00:00","article_modified_time":"2023-07-24T09:39:47+00:00","og_image":[{"width":240,"height":97,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.png","type":"image\/png"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9milie Noguez","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"L\u2019Inserm porte sept projets europ\u00e9ens d\u2019excellence, inclus le projet sur l\u2019antibior\u00e9sistance de Jean-Claude Sirard, Directeur de recherche de l\u2019\u00e9quipe \u00ab Bact\u00e9ries, antibiotiques et immunit\u00e9 (Inserm U1019, Lille).","datePublished":"2020-06-10T08:22:15+00:00","dateModified":"2023-07-24T09:39:47+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/"},"wordCount":238,"commentCount":0,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.png","articleSection":["Actualit\u00e9s"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#respond"]}]},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/","name":"L\u2019Inserm porte sept projets europ\u00e9ens d\u2019excellence, inclus le projet sur l\u2019antibior\u00e9sistance de Jean-Claude Sirard, Directeur de recherche de l\u2019\u00e9quipe \u00ab Bact\u00e9ries, antibiotiques et immunit\u00e9 (Inserm U1019, Lille). - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.png","datePublished":"2020-06-10T08:22:15+00:00","dateModified":"2023-07-24T09:39:47+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.png","width":240,"height":97,"caption":"Cr\u00e9dit : Inserm"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/informations-et-communications\/actualites\/linserm-porte-sept-projets-europeens-dexcellence-inclus-le-projet-sur-lantibioresistance-de-jean-claude-sirard-directeur-de-recherche-de-lequipe-bacteries\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"L\u2019Inserm porte sept projets europ\u00e9ens d\u2019excellence, inclus le projet sur l\u2019antibior\u00e9sistance de Jean-Claude Sirard, Directeur de recherche de l\u2019\u00e9quipe \u00ab Bact\u00e9ries, antibiotiques et immunit\u00e9 (Inserm U1019, Lille)."}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-12 19:43:34","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/3747"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=3747"}],"version-history":[{"count":6,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/3747\/revisions"}],"predecessor-version":[{"id":28851,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/3747\/revisions\/28851"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media\/189"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=3747"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=3747"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=3747"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}